Top Suppliers:I want be here


916151-99-0

916151-99-0 structure
916151-99-0 structure
  • Name: APTO-253
  • Chemical Name: lor-253
  • CAS Number: 916151-99-0
  • Molecular Formula: C22H14FN5
  • Molecular Weight: 367.379
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage G-quadruplex
  • Create Date: 2018-02-01 22:18:53
  • Modify Date: 2025-08-20 11:31:41
  • APTO-253 is an inducer of Kruppel-like factor 4 (KLF4), and also stabilizes Gquadruplex, with anti-proliferative activity.

Name lor-253
Synonyms 2-(5-Fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10]phenanthroline
1H-Imidazo[4,5-f][1,10]phenanthroline, 2-(5-fluoro-2-methyl-1H-indol-3-yl)-
lor 253
APTO-253
Description APTO-253 is an inducer of Kruppel-like factor 4 (KLF4), and also stabilizes Gquadruplex, with anti-proliferative activity.
Related Catalog
Target

KLF4[1], Gquadruplex[3]

In Vitro APTO-253 is an inducer of KLF4. APTO-253 (5 μM) induces KLF4 expression, and enhances apoptosis induced by cisplatin in both SKOV3 and OVCAR3 cells. APTO-253 (5 μM) also leads to G1 phase arrest and reduces S and G2/M phase cells in SKOV3 and OVCAR3 cells[1]. APTO-253 is cytotoxic to Raji and Raji/253R cell lines, with IC50s of 105 ± 2.4 nM and 1387 ± 94 nM, respectively. APTO-253 (0.5 μM) also causes DNA damage in Raji cells. BRCA1/2 deficient cells are hypersensitive to APTO-253. ABCG2 overexpressed HEK-293 cells are resistant to APTO-253 and inhibition of ABCG2 reverses resistance to APTO-253 in Raji/253R[2]. APTO-253 suppresses the proliferation of acute myeloid leukemia (AML) cell lines and various forms of lymphoma cell lines with IC50s ranging from 57 nM to 1.75 µM. APTO-253 (500 nM) also causes G0/G1 cell cycle arrest, induces apoptosis, and down regulates MYC RNA and protein expression in AML lines. APTO-253 (500 nM) leads to DNA damage response pathways in MV4-11 cells. Futhermore, APTO-253 is a potent stabilizer of Gquadruplex (G4) motifs, and demonstrates the greatest propensity for stabilizing the MYC G4 sequences[3].
Cell Assay Cells are plated and treated with vehicle DMSO or APTO-253 (10 concentrations) in 96 well plates for 5 days at 37°C and 5% CO2. Cell viability is measured using CellTiter 96® AQueous one solution cell proliferation assay, and IC50 values are calculated using GraphPad Prism 7 software[3].
References

[1]. Wang B, et al. KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells. Biochem Biophys Res Commun. 2017 Mar 11;484(3):486-492.

[2]. Tsai CY, et al. APTO-253 is a new addition to the repertoire of drugs that can exploit DNA BRCA1/2 deficiency. Mol Cancer Ther. 2018 Apr 6. pii: molcanther.0834.2017.

[3]. Local A, et al. APTO-253 stabilizes G-quadruplex DNA, inhibits MYC expression and induces DNA damage in acute myeloid leukemia cells. Mol Cancer Ther. 2018 Apr 6. pii: molcanther.1209.2017.

Density 1.5±0.1 g/cm3
Boiling Point 718.8±70.0 °C at 760 mmHg
Molecular Formula C22H14FN5
Molecular Weight 367.379
Flash Point 388.5±35.7 °C
Exact Mass 367.123322
PSA 70.25000
LogP 3.33
Vapour Pressure 0.0±2.3 mmHg at 25°C
Index of Refraction 1.843
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.